<DOC>
	<DOCNO>NCT03038750</DOCNO>
	<brief_summary>The risk cardiovascular disease determine complex interplay individual 's genetic make-up , lifestyle , environment . We investigate three potential genetic risk factor observational , cross-sectional , epidemiology pilot study investigate functional variant identify large-scale genome wide association study explain predisposition cardiovascular disease . By determine molecular mechanism regulate EDNRA , PNPLA3 PROCR CVD risk locus , hope translate finding study clinical setting well diagnosis , prevention treatment patient suffer cardiovascular disease . Volunteers enter one study 's three arm base genotype : EDNRA locus ( Arm 1 ) , PNPLA3 locus ( Arm 2 ) , PROCR locus ( Arm 3 ) . Members Cambridge Bioresource match target allele invite participate enter one three study arm . All study assessment visit take place Addenbrooke 's Hospital collaboration University Cambridge . Volunteers participate study maximum 12 month depend study arm assign , complete procedure include medical , demographic lifestyle factor questionnaire ; height , weight body fat assessment ; addition blood pressure/heart rate measurement . Minimally invasive procedure include forearm blood flow venepuncture perform assess primary objective study . The hypothesis arm 1 genetic variant investigate EDNRA gene locus alters function endothelin receptor A leading increase risk coronary artery disease large artery stroke . For study arm 2 , hypothesize genetic variant investigate PNPLA3 increase risk Non-alcoholic fatty liver disease reduce risk Coronary Heart Disease . For study arm 3 , hypothesize genetic variant investigate PROCR locus trigger molecular event potentially increase risk Venous Thrombosis/Venous Thromboembolism nut reduce blood pressure . Furthermore aim investigate anti-inflammatory effect see effect explain reduce risk CHD . This study back BHF Cambridge Center Excellence Wellcome Trust Institutional Strategic Support Fund .</brief_summary>
	<brief_title>Molecular Investigation Genetic Factors CArDiovascular Diseases Using BIOresource Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Volunteers homozygous : Arm 1 : The Aallele rs6841581 , assign 'case ' group . If homozygous Gallele , assign 'control ' group Arm 2 : The Gallele rs738409 , assign 'case ' group . If homozygous Callele , assign 'control ' group Arm 3 : The Gallele rs867186 , assign 'case ' group . If homozygous Aallele , assign 'control ' group Genotype group match sex , i.e . 50 % female Volunteers age 3040 year old Volunteers BMI : Arm 1 : Healthy BMI 18.524.9 Arm 2 : Slightly increase BMI , 2532 Arm 3 : Healthy BMI , 18.524.9 Volunteers willing consume product contain alcohol caffeine 12 hour prior procedure . Additionally , volunteer must agree fast procedure : Arm 1 : At least 4 hour Arm 2 : At least 8 hour Arm 3 : At least 4 hour Have give write informed consent participate Volunteers chronic disease , include cardiovascular disease , liver disease , type 1 type 2 diabetes autoimmune disease cancer Biological firstdegree relative ( parent , brother sister ) suffer one condition describe Current smoker . Exsmokers suitable stop smoke &gt; 10 year ago Volunteers consistently high blood pressure , &gt; 140/90 mmHg Volunteers high cholesterol level , e.g . total cholesterol level &gt; 6 mmol/l Volunteers drink regularly &gt; 14 unit week</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Genetic Risk Markers Cardiovascular Disease</keyword>
	<keyword>Non-Alcoholic Fatty Liver Disease</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Venous Thromboses</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Coronary Artery Disease</keyword>
</DOC>